The content on this site is intended for healthcare professionals only
The p-medicine project and ECRIN
Highlights of the p-medicine project
Transarterial chemoembolization with or without sorafenib for intermediate-stage hepatocellular carcinoma
Immunotherapy developments in lung, head and neck, liver and PD-1 repsonse prediction
Promising results for nivolumab in advanced liver cancer
Nivolumab shows highly promising activity in advanced liver cancer in early-stage trial
Real-world targeted treatment based on whole genome sequencing difficult in pancreatic cancer
PARP inhibitor combo shows early promise for patients with and without BRCA mutations
Incidences of liver cancer rising in the USA
The role of health economics in cancer outcomes research
Biobanking biological materials and linkage to clinical information
2nd EurocanPlatform translational research course is good for networking
